Solventum Corporation (SOLV)
$
75.88
+1.69 (2.23%)
Key metrics
Financial statements
Free cash flow per share
2.2165
Market cap
13.1 Billion
Price to sales ratio
1.5802
Debt to equity
2.4258
Current ratio
1.1898
Income quality
2.0423
Average inventory
915.5 Million
ROE
0.1235
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Solventum Corporation, a healthcare company incorporated in 2023 and based in Saint Paul, Minnesota, is focused on developing, manufacturing, and commercializing a diverse range of solutions to meet critical customer and patient needs. The company operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers an array of products, including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Meanwhile, the Dental Solutions segment provides an extensive suite of dental and orthodontic products such as brackets, aligners, restorative cements, and bonding agents. Health Information Systems is dedicated to delivering software solutions like computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. In addition, the Purification and Filtration segment features advanced purification and filtration technologies encompassing filters, purifiers, cartridges, and membranes. The company's operating expenses amount to $3,557,000,000.00 encompassing various operational costs incurred. With reported revenue of $8,254,000,000.00 the company reflects a strong market presence. Moreover, the operating income ratio stands at 0.13 indicating the company's operational profitability margin, while the weighted average number of shares outstanding is 173,200,000.00 highlighting the company's shareholder base. The company's stock is identified with the symbol 'SOLV' in the market. Investors will find the stock reasonably priced at $75.88 appealing to a broad range of market participants. With an average trading volume of 991,951.00 the stock indicates moderate liquidity, which can facilitate trading activities for shareholders. Solventum Corporation boasts a mid-range market capitalization of $13,128,220,370.00 establishing it as a steady performer. As a key player in the Medical - Care Facilities industry, the company significantly contributes to the overall market landscape, driving innovation and growth within the healthcare sector, wherein it belongs to the Healthcare sector. This combination of solid financial performance and strategic positioning underscores Solventum Corporation’s potential as a valuable investment opportunity within the dynamic healthcare market.
Investing in Solventum Corporation (SOLV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Solventum Corporation stock to fluctuate between $47.16 (low) and $85.92 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2025-07-10, Solventum Corporation's market cap is $13,128,220,370, based on 173,012,920 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, Solventum Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Solventum Corporation (SOLV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SOLV. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $8,254,000,000 | EPS: $2.77 | Growth: -64.44%.
Visit https://www.solventum.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $85.92 (2025-02-26) | All-time low: $47.16 (2024-07-16).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Solventum beats Q1 estimates, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
zacks.com
Solventum (SOLV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SOLV broke through the 200-day moving average, which suggests a long-term bullish trend.
seekingalpha.com
Solventum Corporation (NYSE:SOLV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Frederick Wise - Stifel, Nicolaus & Company, Inc. Jason Bednar - Piper Sandler & Co. David Roman - Goldman Sachs Group, Inc. Travis Steed - Bank of America Steven Valiquette - Mizuho Securities Operator Good afternoon. My name is Amy [ph] and I will be your conference call operator for today.
seekingalpha.com
Solventum Corporation's stock has dropped 20% since February despite beating earnings and revenue expectations in its last two quarterly reports. SOLV operates in four divisions: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration, with a market cap of $11.5 billion. The company recently announced the sale of its Purification and Filtration business to Thermo Fisher at what seems a more than solid price.
zacks.com
SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
zacks.com
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
zacks.com
Investors looking for stocks in the Medical Services sector might want to consider either Solventum (SOLV) or Doximity (DOCS). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com
Solventum (SOLV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
zacks.com
Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zacks.com
Solventum's fourth-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
See all news